What does Cogent Biosciences, Inc. do?

Jun 22 2025 06:26 PM IST
share
Share Via
Cogent Biosciences, Inc. is a biopharmaceutical company focused on developing precision therapies for genetically defined diseases and curative cell therapies for solid tumors. It operates as a micro-cap company with a market cap of approximately $867.59 million and reported a net profit loss of $72 million in March 2025.
Overview:
Cogent Biosciences, Inc. is a biopharmaceutical company focused on developing precision therapies for genetically defined diseases and curative cell therapies for solid tumors, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.

Financial Snapshot:
Most recent Net Sales: Not available
Most recent Net Profit: -72 Million (Quarterly Results - Mar 2025)
Market-cap: USD 867.59 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -1.11
Return on Equity: -123.06%
Price to Book: 3.96

Contact Details:
Address: 200 CAMBRIDGE PARK DRIVE, SUITE 3100, CAMBRIDGE MA: 02140
Tel: ['1 617 9455576', '1 212 3621200']
Website: https://www.unumrx.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Cogent Biosciences, Inc. technically bullish or bearish?
Sep 23 2025 11:19 AM IST
share
Share Via
Is Cogent Biosciences, Inc. technically bullish or bearish?
Sep 22 2025 06:05 PM IST
share
Share Via
Is Cogent Biosciences, Inc. technically bullish or bearish?
Sep 20 2025 07:29 PM IST
share
Share Via
Is Cogent Biosciences, Inc. technically bullish or bearish?
Jun 25 2025 08:36 AM IST
share
Share Via
Who are in the management team of Cogent Biosciences, Inc.?
Jun 22 2025 10:21 PM IST
share
Share Via
How big is Cogent Biosciences, Inc.?
Jun 22 2025 05:50 PM IST
share
Share Via